Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

iRhythm Technologies, Inc. develops, produces, and distributes medical instruments. The Company offers cardiac rhythm monitoring devices for palpitation, shortness of breath, and fatigue. iRhythm Technologies serves physician, clinical staff, and patients in the United States.
Website: irhythmtech.com



Growth: Good revenue growth rate 27.4%, there is acceleration compared to average historical growth rates 25.4%. The revenue growth dynamics is moderately stable Site traffic for the last 3 months showed a change of 0.0%

Profitability: LTM EBITDA margin is negative, -10.6%. On average the margin is improving steadily. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 40% of quarters (showing a gain of -$0.17 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 0.0% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 118.2% higher than minimum and 33.9% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.3x by EV / Sales multiple , the company can be 63.6% overvalued

Key Financials (Download financials)

Ticker: IRTC
Share price, USD:  (-2.1%)124.5
year average price 156.56  


year start price 160.99 2025-08-07

max close price 188.30 2025-11-25

min close price 102.42 2026-06-17

current price 124.50 2026-08-06
Common stocks: 32 258 000

Dividend Yield:  0.0%
EV / Sales: 6.3x
Margin (EBITDA LTM / Revenue): -10.6%
Fundamental value created in LTM:
Market Cap ($m): 4 101
Net Debt ($m): 147
EV (Enterprise Value): 4 248
Price to Book: 32.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-21prnewswire.com

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm

2026-01-15globenewswire.com

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm

2026-01-12seekingalpha.com

iRhythm Technologies, Inc. (IRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2025-12-03seekingalpha.com

iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

2025-11-17prnewswire.com

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm

2025-11-12newsfilecorp.com

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm

2025-11-11globenewswire.com

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025

2025-11-05barrons.com

iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating

2025-10-30seekingalpha.com

iRhythm Technologies, Inc. (IRTC) Q3 2025 Earnings Call Transcript

2025-09-02zacks.com

IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-30 2025-07-31 2024-10-30 2024-08-01 2024-05-02 2023-11-02 2023-08-04 2023-05-04 2022-11-04
acceptedDate 2025-10-30 17:21:56 2025-07-31 17:23:19 2025-02-20 17:21:12 2024-10-30 17:19:32 2024-08-01 17:10:49 2024-05-02 17:12:44 2024-02-22 17:11:08 2023-11-02 17:13:45 2023-08-04 08:26:52 2023-05-04 17:15:19 2023-02-23 17:16:48 2022-11-04 17:07:43 2022-02-28 08:03:24 2021-02-26 17:06:46
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 193M 187M 592M 148M 148M 132M 493M 125M 124M 111M 411M 104M 323M 265M
costOfRevenue 56M 54M 184M 46M 45M 44M 161M 42M 38M 36M 129M 33M 109M 70M
grossProfit 137M 133M 408M 101M 103M 88M 332M 82M 86M 76M 282M 71M 214M 195M
grossProfitRatio 0.711 0.712 0.688 0.699 0.663 0.662 0.695 0.679 0.683
researchAndDevelopmentExpenses 21M 23M 104M 16M 20M 17M 60M 16M 14M 15M 47M 11M 39M 41M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 124M 126M 419M 103M 107M 109M 386M 94M 91M 100M 322M 81M 275M 197M
otherExpenses 0 2M 641 000 0 0 0 11M 0 1M 1M 27M 0 0 0
operatingExpenses 146M 152M 523M 119M 126M 126M 457M 110M 105M 115M 395M 92M 314M 239M
costAndExpenses 201M 205M 707M 165M 171M 170M 618M 152M 143M 151M 525M 125M 423M 309M
interestIncome 6M 5M 22M 6M 6M 3M 6M 2M 1M 0 2M 0 118 000 0
interestExpense 3M 3M 13M 3M 3M 3M 4M 927 000 832 000 950 000 4M 614 000 1M 2M
depreciationAndAmortization 4M 7M 26M 6M 6M 6M 22M 6M 5M 6M 20M 365 000 17M 13M
ebitda 2M -5M -74M -36M -10M -32M -97M -20M -17M -33M -92M -21M -83M -29M
ebitdaratio 0.012 -0.029 -0.246 -0.112 -0.241 -0.164 -0.14 -0.297 -0.199
operatingIncome -8M -19M -116M -50M -23M -38M -125M -28M -19M -40M -114M -21M -100M -44M
operatingIncomeRatio -0.044 -0.1 -0.341 -0.155 -0.289 -0.222 -0.152 -0.354 -0.203
totalOtherIncomeExpensesNet 3M 4M 3M 4M 3M -7M 3M 682 000 1M 482 000 -2M -249 000 -1M 72 000
incomeBeforeTax -5M -14M -113M -46M -20M -46M -123M -27M -18M -39M -116M -21M -101M -44M
incomeBeforeTaxRatio -0.027 -0.077 -0.312 -0.135 -0.346 -0.216 -0.147 -0.35 -0.205
incomeTaxExpense 24 000 -183 000 565 000 188 000 194 000 32 000 750 000 195 000 213 000 87 000 269 000 116 000 367 000 229 000
netIncome -5M -14M -113M -46M -20M -46M -123M -27M -18M -39M -116M -21M -101M -44M
netIncomeRatio -0.027 -0.076 -0.313 -0.136 -0.346 -0.218 -0.149 -0.351 -0.207
eps -0.16 -0.45 -3.63 -1.48 -0.65 -1.47 -4.04 -0.89 -0.61 -1.29 -3.88 -0.71 -3.46 -1.58
epsdiluted -0.16 -0.45 -1.48 -0.65 -1.47 -0.89 -0.61 -1.29 -0.71
weightedAverageShsOut 32M 32M 31M 31M 31M 31M 31M 31M 31M 30M 30M 30M 29M 28M
weightedAverageShsOutDil 33M 32M 31M 31M 31M 31M 31M 31M 31M 30M 30M 30M 29M 28M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-20 2024-02-22 2023-02-23 2022-02-28 2021-02-26
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 9M 3M -2M -1M -2M
ebit -100M -119M -112M -100M -42M
nonOperatingIncomeExcludingInterest -16M -6M -2M -118 000 -2M
netIncomeFromContinuingOperations -113M -123M -116M -101M -44M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -113M -123M -116M -101M -44M
epsDiluted -3.63 -4.04 -3.88 -3.46 -1.58

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-30 2025-07-31 2024-10-30 2024-08-01 2024-05-02 2023-11-02 2023-08-04 2023-05-04 2022-11-04
acceptedDate 2025-10-30 17:21:56 2025-07-31 17:23:19 2025-02-20 17:21:12 2024-10-30 17:19:32 2024-08-01 17:10:49 2024-05-02 17:12:44 2024-02-22 17:11:08 2023-11-02 17:13:45 2023-08-04 08:26:52 2023-05-04 17:15:19 2023-02-23 17:16:48 2022-11-04 17:07:43 2022-02-28 08:03:24 2021-02-26 17:06:46
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 256M 309M 420M 520M 551M 520M 36M 47M 62M 53M 79M 71M 128M 89M
shortTermInvestments 310M 236M 116M 2M 11M 49M 98M 111M 103M 124M 134M 132M 112M 247M
cashAndShortTermInvestments 565M 546M 536M 522M 561M 569M 134M 158M 165M 176M 213M 204M 239M 335M
netReceivables 76M 82M 80M 77M 86M 90M 61M 50M 51M 50M 50M 61M 46M 30M
inventory 20M 18M 14M 15M 15M 15M 14M 14M 14M 16M 15M 14M 10M 5M
otherCurrentAssets 19M 18M 16M 13M 15M 14M 22M 12M 12M 12M 11M 7M 10M 7M
totalCurrentAssets 680M 664M 646M 628M 678M 687M 231M 234M 242M 254M 289M 286M 306M 378M
propertyPlantEquipmentNet 193M 184M 173M 168M 164M 160M 153M 158M 148M 142M 136M 134M 141M 119M
goodwill 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000
intangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
goodwillAndIntangibleAssets 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000 862 000
longTermInvestments 68M 65M 62M 59M 26M 11M 3M 3M 0 0 0 0 0 0
taxAssets 0 0 0 0 -1 -1 0 -3M 0 0 0 0 0 0
otherNonCurrentAssets 54M 50M 50M 54M 50M 50M 45M 47M 39M 25M 22M 20M 16M 14M
totalNonCurrentAssets 315M 300M 286M 282M 242M 222M 202M 205M 187M 168M 159M 155M 157M 134M
otherAssets 0 0 0 0 1 1 0 0 0 0 0 0 0 0
totalAssets 995M 964M 931M 910M 919M 910M 433M 440M 429M 422M 448M 440M 463M 512M
accountPayables 8M 13M 7M 8M 13M 8M 6M 7M 7M 10M 8M 7M 11M 4M
shortTermDebt 17M 16M 0 31M 31M 15M 0 15M 14M 14M 0 13M 12M 12M
taxPayables 0 2M 4M 4M 3M 3M 3M 3M 0 0 2M 0 0 0
deferredRevenue 4M 3M 3M 3M 3M 3M 3M 3M 4M 3M 3M 3M 3M 930 000
otherCurrentLiabilities 118M 97M 35M 55M 47M 70M 1M 77M 64M 55M 19M 60M 9M 14M
totalCurrentLiabilities 147M 132M 111M 100M 98M 97M 107M 102M 89M 82M 89M 84M 88M 66M
longTermDebt 716M 718M 646M 720M 721M 644M 35M 117M 115M 117M 35M 116M 10M 21M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 10M 10M 9M 18M 940 000 79M 1M 1M 1M 1M 1M 94M 697 000 2M
totalNonCurrentLiabilities 726M 728M 730M 738M 722M 723M 116M 118M 116M 118M 119M 118M 96M 104M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 87M 90M 90M 92M 78M 95M 97M 94M 96M 96M 94M 96M 89M
totalLiabilities 873M 860M 841M 838M 820M 819M 223M 220M 206M 200M 208M 201M 183M 170M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 32 000 32 000 31 000 31 000 31 000 31 000 31 000 31 000 30 000 30 000 28 000 28 000 27 000 27 000
retainedEarnings -809M -804M -759M -758M -711M -691M -646M -607M -580M -561M -522M -502M -406M -305M
accumulatedOtherComprehensiveIncomeLoss 285 000 -26 000 165 000 -66 000 182 000 -89 000 -112 000 -15 000 -152 000 -69 000 -396 000 -681 000 -61 000 11 000
othertotalStockholdersEquity 931M 907M 829M 810M 782M 827M 804M 783M 742M
totalStockholdersEquity 122M 104M 91M 72M 99M 90M 210M 220M 224M 222M 240M 239M 280M 342M
totalEquity 122M 104M 91M 72M 99M 90M 210M 220M 224M 222M 240M 239M 280M 342M
totalLiabilitiesAndStockholdersEquity 995M 964M 910M 919M 910M 440M 429M 422M 440M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 995M 964M 931M 910M 919M 910M 433M 440M 429M 422M 448M 440M 463M 512M
totalInvestments 378M 301M 178M 62M 37M 60M 101M 111M 103M 124M 134M 132M 112M 247M
totalDebt 733M 735M 737M 735M 737M 737M 130M 132M 129M 131M 131M 129M 118M 122M
netDebt 477M 426M 317M 216M 186M 217M 94M 84M 68M 78M 52M 58M -10M 34M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-20 2024-02-22 2023-02-23 2022-02-28 2021-02-26
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 80M 61M 50M 46M 30M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 0 0
totalPayables 7M 13M 10M 11M 4M
otherPayables 0 7M 2M 0 0
accruedExpenses 50M 75M 44M 43M 27M
capitalLeaseObligationsCurrent 16M 15M 13M 11M 8M
capitalLeaseObligationsNonCurrent 75M 80M 83M 85M 81M
treasuryStock -25M 0 0 0 0
additionalPaidInCapital 875M 856M 762M 686M 646M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC IRTC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-30 2025-07-31 2024-10-30 2024-08-01 2024-05-02 2023-11-02 2023-08-04 2023-05-04 2022-11-04
acceptedDate 2025-10-30 17:21:56 2025-07-31 17:23:19 2025-02-20 17:21:12 2024-10-30 17:19:32 2024-08-01 17:10:49 2024-05-02 17:12:44 2024-02-22 17:11:08 2023-11-02 17:13:45 2023-08-04 08:26:52 2023-05-04 17:15:19 2023-02-23 17:16:48 2022-11-04 17:07:43 2022-02-28 08:03:24 2021-02-26 17:06:46
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -5M -14M 0 -46M -20M -46M -123M -27M -18M -39M -116M -21M -101M -44M
depreciationAndAmortization 7M 4M 0 1M 6M 6M 22M 6M 5M 5M 20M 438 000 17M 7M
deferredIncomeTax 0 0 0 0 0 0 0 13M 15M 0 0 0 0 32M
stockBasedCompensation 21M 23M 0 17M 22M 21M 77M 21M 14M 18M 58M 13M 55M 42M
changeInWorkingCapital -13M -15M -99M 74M -16M -57M -102M -11M -20M -35M -66M -3M -46M -56M
accountsReceivables -19M -27M -92M -9M -15M -45M -81M -13M -18M -21M -62M -18M -54M -38M
inventory -2M -4M -224 000 425 000 -543 000 -923 000 979 000 1M 2M -1M -5M -29 000 -5M -1M
accountsPayables 0 15M -7M 2M 2M -13M -2M 62 000 -3M 2M -3M 1M 6M -4M
otherWorkingCapital 8M 868 000 436 000 80M -3M 936 000 -20M 1M -2M -15M 4M 14M 6M -13M
otherNonCashItems 26M 30M 103M -22M 68M 116M 76M -507 000 -35 000 20M 81M 14M 39M 6M
netCashProvidedByOperatingActivities 35M 28M 3M 24M 12M -52M -50M 1M -5M -31M -23M 4M -38M -14M
investmentsInPropertyPlantAndEquipment -15M -10M -34M -9M -8M -10M -40M -9M -9M -8M -30M -6M -28M -14M
acquisitionsNet 0 0 0 0 0 0 0 6M 0 0 0 0 0 119M
purchasesOfInvestments -173M -135M 0 -40M -15M -2M -167M -36M -42M -34M -189M -46M -122M -278M
salesMaturitiesOfInvestments 99M 45M 0 9M 38M 52M 207M 30M 61M 46M 166M 17M 256M 159M
otherInvestingActivites 0 0 -15M 23M 50M -6M 0 0 0
netCashUsedForInvestingActivites -89M -101M -55M 15M 40M -15M 9M 4M -35M
debtRepayment 0 0 -183 000 0 -60M 0 0 0 0
commonStockIssued 0 7M -661M 5M 662M 66 000 0 905 000 0
commonStockRepurchased 0 0 -25M 25M 0 -25M 0 0 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites 825 000 0 148 000 4M -72M 66 000 0 0 2M
netCashUsedProvidedByFinancingActivities 825 000 7M -35 000 4M 505M 66 000 4M 905 000 2M
effectOfForexChangesOnCash -4000 18 000 -6000 5000 -9000 -4000 -169 000 76 000 -9M 0 0 0 0 0
netChangeInCash -54M -66M 392M -23M 30M 484M -43M -14M 9M -26M -49M -30M 39M 68M
cashAtEndOfPeriod 264M 317M 428M 528M 551M 520M 36M 47M 62M 53M 79M 71M 128M 89M
cashAtBeginningOfPeriod 317M 384M 36M 551M 520M 36M 79M 62M 53M 79M 128M 101M 89M 20M
operatingCashFlow 35M 28M 3M 24M 12M -52M -50M 1M -5M -31M -23M 4M -38M -14M
capitalExpenditure -15M -10M -34M -9M -8M -10M -40M -9M -9M -8M -30M -6M -28M -14M
freeCashFlow 20M 17M -31M 16M 3M -62M -91M -8M -14M -39M -53M -3M -66M -27M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-20 2024-02-22 2023-02-23 2022-02-28 2021-02-26
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -89M 0 0 0 -119M
netCashProvidedByInvestingActivities -123M -1M -52M 105M -132M
netDebtIssuance 620M 0 14M -12M -2M
longTermNetDebtIssuance 620M 0 14M -12M -2M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance -25M 0 0 9M 206M
netCommonStockIssuance -25M 0 0 9M 206M
commonStockIssuance 0 0 0 9M 206M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -83M 9M 13M -26M 10M
netCashProvidedByFinancingActivities 511M 9M 27M -29M 214M
incomeTaxesPaid 923 000 1M 287 000 0 0
interestPaid 6M 3M 3M 0 0

Earning call transcript

2025 q3
2025-10-30 ET (fiscal 2025 q3)
2025 q2
2025-07-31 ET (fiscal 2025 q2)
2025 q1
2025-05-01 ET (fiscal 2025 q1)
2024 q4
2025-02-21 ET (fiscal 2024 q4)
2024 q3
2024-10-30 ET (fiscal 2024 q3)
2024 q2
2024-08-02 ET (fiscal 2024 q2)
2024 q1
2024-05-04 ET (fiscal 2024 q1)
2023 q4
2024-02-22 ET (fiscal 2023 q4)
2023 q3
2023-11-02 ET (fiscal 2023 q3)
2023 q2
2023-08-03 ET (fiscal 2023 q2)
2023 q1
2023-05-07 ET (fiscal 2023 q1)
2022 q4
2023-02-23 ET (fiscal 2022 q4)
2022 q3
2022-11-01 ET (fiscal 2022 q3)
2022 q2
2022-08-06 ET (fiscal 2022 q2)
2022 q1
2022-05-07 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2026-05-19 20:05 ET
iRhythm Holdings to Participate in Upcoming Investor Conferences
2026-04-30 ET
iRhythm Holdings Announces First Quarter 2026 Financial Results
2026-04-28 ET
iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference
2026-04-27 ET
New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy
2026-04-16 ET
iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026
2026-03-30 ET
Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform
2026-03-12 ET
iRhythm Holdings Appoints Jason Patten to its Board of Directors
2026-02-19 ET
iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results
2026-02-05 21:30 ET
iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
2026-01-12 ET
iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference
2025-12-29 ET
iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
2025-11-21 ET
New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population
2025-11-11 ET
iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025
2025-11-04 ET
iRhythm Technologies to Participate in Upcoming Investor Conferences
2025-10-30 20:05 ET
iRhythm Technologies Announces Third Quarter 2025 Financial Results
2025-10-16 ET
iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025
2025-08-29 ET
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service
2025-08-29 ET
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service
2025-08-20 ET
iRhythm Technologies to Participate in Upcoming Investor Conferences
2025-08-18 ET
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority
2025-07-31 ET
iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions
2025-07-31 ET
iRhythm Technologies Announces Second Quarter 2025 Financial Results
2025-07-17 ET
iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025
2025-07-07 ET
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
2025-06-23 ET
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
2025-06-17 ET
iRhythm Technologies, Inc. (NASDAQ: IRTC) Investor Alert: Schubert Jonckheer & Kolbe LLP Investigating Possible Shareholder Claims for False Statements and Insider Trading
2025-05-21 ET
iRhythm Technologies to Participate in Upcoming Investor Conferences
2025-05-01 ET
iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection
2025-05-01 ET
iRhythm Technologies Announces First Quarter 2025 Financial Results
2025-04-29 ET
iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference
2025-04-28 ET
iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring
2025-04-17 ET
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025
2025-04-16 ET
iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability
2025-04-15 ET
Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer
2025-03-31 ET
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
2025-02-20 ET
iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results
2025-02-06 ET
iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
2025-01-13 ET
iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference
2024-12-30 ET
iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
2024-11-20 ET
iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
2024-11-18 ET
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring
2024-11-05 ET
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
2024-10-30 20:08 ET
iRhythm Technologies Announces Third Quarter 2024 Financial Results
2024-10-28 12:02 ET
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
2024-10-21 20:05 ET
iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device
2024-10-16 20:05 ET
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
2024-09-11 12:05 ET
iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
2024-09-09 12:05 ET
iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting
2024-09-04 11:30 ET
iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
2024-09-01 17:33 ET
iRhythm Technologies Announces Results of GUARD-AF Trial
2024-08-29 12:00 ET
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain
2024-08-29 12:00 ET
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain
2024-08-21 20:05 ET
iRhythm Technologies to Participate in Upcoming Investor Conferences in September
2024-08-01 20:06 ET
iRhythm Technologies Announces Chief Financial Officer Transition
2024-08-01 20:05 ET
iRhythm Technologies Announces Second Quarter 2024 Financial Results
2024-07-18 20:05 ET
iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024
2024-06-17 20:05 ET
iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation
2024-06-04 20:05 ET
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
2024-05-22 20:05 ET
iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference
2024-05-02 20:05 ET
iRhythm Technologies Announces First Quarter 2024 Financial Results
2024-04-18 20:05 ET
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
2024-03-08 21:30 ET
iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes
2024-03-08 21:30 ET
iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes
2024-03-05 04:42 ET
iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029
2024-03-05 04:42 ET
iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029
2024-03-04 11:45 ET
iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes
2024-03-04 11:45 ET
iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes
2024-02-29 21:30 ET
iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients
2024-02-22 21:05 ET
iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results
2024-02-08 21:05 ET
iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
2024-01-08 13:30 ET
iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference
2024-01-05 13:05 ET
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
2024-01-03 13:00 ET
iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System
2024-01-03 13:00 ET
iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System
2023-12-26 21:30 ET
iRhythm Technologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-11-20 14:00 ET
Derrick Sung Joins Aerin Medical as Chief Financial Officer
2023-11-13 13:05 ET
New Research Presented at American Heart Association’s 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization
2023-11-02 20:05 ET
iRhythm Technologies Announces Third Quarter 2023 Financial Results
2023-10-19 20:05 ET
iRhythm Technologies to Report Third Quarter 2023 Financial Results on November 2, 2023
2023-09-26 12:05 ET
iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor
2023-09-26 ET
iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor
2023-08-29 12:30 ET
iRhythm Technologies to Participate in Two Investor Conferences in September
2023-08-03 20:10 ET
Zio Granted High Medical Needs Designation by the Japanese Ministry of Health, Labour, and Welfare
2023-08-03 20:05 ET
iRhythm Technologies Announces Second Quarter 2023 Financial Results
2023-07-20 20:05 ET
iRhythm Technologies to Report Second Quarter 2023 Financial Results on August 3, 2023
2023-07-18 12:30 ET
NAMCP Independent Third-Party Review Validates Value Proposition of iRhythm Zio XT Service to Health Systems and Payers
2023-06-06 13:00 ET
iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments
2023-05-24 20:05 ET
iRhythm Technologies to Present at the William Blair 43rd Annual Growth Stock Conference
2023-05-22 12:30 ET
New Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias
2023-05-04 20:05 ET
iRhythm Technologies Announces First Quarter 2023 Financial Results
2023-04-20 20:05 ET
iRhythm Technologies to Report First Quarter 2023 Financial Results on May 4, 2023
2023-04-12 20:30 ET
iRhythm Technologies Releases 2022 Environmental, Social, and Governance Report Reflecting Strategy to Deliver Purpose-Driven Growth
2023-03-06 13:30 ET
Large Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG Monitors
2023-03-02 13:30 ET
Four New Studies Featuring Zio® by iRhythm to be Presented at ACC.23/WCC
2023-02-23 21:05 ET
iRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results
2023-02-09 21:05 ET
iRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
2023-01-09 13:30 ET
iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference
2022-12-27 21:30 ET
iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
2022-12-20 ET
HeartBeam (NASDAQ: BEAT) Looks to Disrupt to Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product
2022-11-07 21:05 ET
Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22
2022-11-06 17:30 ET
New Research Confirms that Zio® by iRhythm Provides High Value From a Health Economic Perspective
2022-11-02 12:30 ET
iRhythm® Technologies Comments on the Announcement of the Medicare Physician Fee Schedule Final Rule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
2022-11-01 20:05 ET
iRhythm Technologies Announces Third Quarter 2022 Financial Results
2022-10-20 20:05 ET
iRhythm Technologies to Report Third Quarter 2022 Financial Results on November 1, 2022
2022-09-21 12:30 ET
iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day
2022-08-31 12:30 ET
iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022
2022-08-04 20:05 ET
iRhythm Technologies Announces Second Quarter 2022 Financial Results
2022-08-04 12:00 ET
Paragon 28 Announces Changes to its Board of Directors
2022-07-28 20:30 ET
iRhythm Technologies to Present at the Canaccord Genuity 42nd Annual Growth Conference
2022-07-25 20:15 ET
iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence
2022-07-22 12:30 ET
iRhythm Gains FDA Clearance for its Clinically Integrated ZEUS System
2022-07-18 20:10 ET
iRhythm Technologies Announces Chief Commercial Officer Transition and Schedules Second Quarter Earnings Release and Conference Call for August 4, 2022
2022-07-08 12:30 ET
iRhythm® Technologies Comments on the Proposed Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
2022-05-25 20:05 ET
iRhythm Technologies to Present at the 42nd Annual William Blair Growth Stock Conference
2022-05-05 20:05 ET
iRhythm Technologies Announces First Quarter 2022 Financial Results
2022-04-28 20:05 ET
iRhythm Technologies Announces Hiring of Dr. Mintu Turakhia as Chief Medical Officer and Chief Scientific Officer
2022-04-21 20:05 ET
iRhythm Technologies to Report First Quarter 2022 Financial Results on May 5, 2022
2022-04-03 16:35 ET
Zio® by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF
2022-03-29 20:05 ET
iRhythm Technologies Announces Amendment to Term Loan Agreement
2022-03-14 12:30 ET
iRhythm® Technologies Announces Kevin King to Retire from Board of Directors
2022-02-28 17:59 ET
Zio® by iRhythm Shows Significantly Higher Documentation of Atrial Fibrillation and Atrial Flutter Compared to Holter Monitors, Event Monitors
2022-02-23 21:05 ET
iRhythm Technologies Announces Fourth Quarter and Full Year 2021 Financial Results
2022-02-18 07:00 ET
Karen L. Ling joins Galderma’s Advisory Committee
2022-02-09 21:05 ET
iRhythm Technologies to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
2022-01-10 23:29 ET
iRhythm Technologies Comments on Medicare Administrative Contractor 2022 Rate Update
2021-12-29 21:05 ET
iRhythm® Technologies to Present at the 40th Annual J.P. Morgan Healthcare Conference
2021-11-04 20:05 ET
iRhythm Technologies Announces Third Quarter 2021 Financial Results
2021-11-03 01:37 ET
iRhythm Technologies Comments on Centers for Medicare and Medicaid Services 2022 Medicare Physician Fee Schedule Final Rule
2021-10-21 20:05 ET
iRhythm Technologies to Report Third Quarter 2021 Financial Results on November 4, 2021
2021-10-12 20:05 ET
iRhythm® Technologies Announces Changes to Its Board of Directors
2021-10-05 20:05 ET
mSToPS Clinical Trial Demonstrates Zio by iRhythm Significantly Improves Health Outcomes for At-Risk Patient Populations
2021-09-13 12:15 ET
iRhythm® Technologies Names Quentin Blackford President and Chief Executive Officer
2021-08-26 20:05 ET
iRhythm® Technologies to Present at the 19th Annual Morgan Stanley Global Healthcare Conference
2021-08-05 20:05 ET
iRhythm Technologies Announces Second Quarter 2021 Financial Results
2021-07-29 20:05 ET
iRhythm® Technologies to Present at the 41st Annual Canaccord Genuity Global Growth Conference
2021-07-22 20:05 ET
iRhythm Technologies to Report Second Quarter 2021 Financial Results on August 5, 2021
2021-07-14 10:00 ET
iRhythm® Technologies Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Medicare Physician Fee Schedule
2021-07-08 13:00 ET
iRhythm® Technologies and the National Association of Managed Care Physicians Partner to Study the Value of Ambulatory Cardiac Monitoring Solutions
2021-06-01 20:05 ET
iRhythm® Technologies Announces Leadership Transition
2021-05-28 22:19 ET
iRhythm Technologies to Present at the 41st Annual William Blair Growth Stock Conference
2021-05-24 20:39 ET
iRhythm® Technologies Continues to Fuel Innovation in Cardiac Monitoring and Unveils Two FDA Clearances for Superior Patient Care
2021-05-06 20:06 ET
iRhythm Technologies Announces First Quarter 2021 Financial Results
2021-04-22 20:05 ET
iRhythm Technologies to Report First Quarter 2021 Financial Results on May 6, 2021
2021-04-12 11:00 ET
iRhythm® Technologies Provides Statement on Medicare Administrative Contractor (MAC) Novitas’s Updated Rate Publication and Provides Commentary on Results for the First Quarter 2021
2021-04-10 18:20 ET
iRhythm® Technologies Announces Conference Call to Discuss Medicare Administrative Contractor (MAC) Novitas’s Updated Rate Publication
2021-02-25 21:05 ET
iRhythm Technologies Announces Fourth Quarter and Full Year 2020 Financial Results
2021-02-24 16:00 ET
Study Published in JAMA Cardiology Finds Zio by iRhythm Proactively Identifies Atrial Fibrillation, Increases Detection Tenfold
2021-02-22 16:00 ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iRhythm Technologies, Inc. (IRTC)
2021-02-22 15:11 ET
IRTC APRIL DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  iRhythm Technologies, Inc.– IRTC
2021-02-12 23:00 ET
IRTC Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against iRhythm Technologies, Inc. (NASDAQ: IRTC); Lead Plaintiff Deadline is April 2, 2021
2021-02-11 21:05 ET
iRhythm Technologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
2021-01-29 18:55 ET
iRhythm Technologies Provides Statement on Medicare Administrative Contractor (MAC) Novitas Recent Rate Publication
2020-12-29 23:08 ET
iRhythm Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-14 21:40 ET
iRhythm Technologies President and CEO Kevin King to Retire; Michael Coyle Joins Company as President and CEO Effective January 12, 2021
2020-12-02 08:53 ET
iRhythm Technologies Comments on Centers for Medicare and Medicaid Services 2021 Medicare Physician Fee Schedule Final Rule
2020-12-01 08:30 ET
iRhythm Technologies Receives Positive National Guidance in First of its Kind Digital Health Pilot with National Institute for Health and Care Excellence
2020-12-01 08:30 ET
iRhythm Technologies Receives Positive National Guidance in First of its Kind Digital Health Pilot with National Institute for Health and Care Excellence
2020-11-16 15:30 ET
Zio by iRhythm Detects Previously Undiagnosed Atrial Fibrillation and Helps to Prevent Hospitalizations, Stroke, and Death as a Result
2020-11-13 14:00 ET
iRhythm Technologies Announces Data from mSToPS Clinical Trial to be Presented in a Late-Breaking Scientific Session at American Heart Association 2020
2020-11-05 21:05 ET
iRhythm Technologies Announces Third Quarter 2020 Financial Results
2020-10-22 20:05 ET
iRhythm Technologies to Report Third Quarter 2020 Financial Results on November 5, 2020
2020-09-08 09:54 ET
iRhythm Technologies Announces NHS Funding After Winning Artificial Intelligence in Health and Care Award
2020-09-08 09:53 ET
iRhythm Technologies Announces NHS Funding After Winning Artificial Intelligence in Health and Care Award
2020-09-01 20:05 ET
iRhythm Technologies to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
2020-08-24 14:37 ET
Digital Transformation of Healthcare: CEO’s of ONEM, HCAT, DOCRF, IRTC, Discuss Telemedicine, Big Data, and Diagnostics
2020-08-21 20:05 ET
iRhythm Technologies Announces Closing of Follow-on Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
2020-08-19 05:00 ET
iRhythm Technologies Announces Pricing of Upsized Public Offering of Common Stock
2020-08-18 20:51 ET
iRhythm Technologies Announces Proposed Public Offering of Common Stock
2020-08-06 20:05 ET
iRhythm Technologies Announces Second Quarter 2020 Financial Results
2020-08-04 18:01 ET
iRhythm Technologies to Provide Commentary on the Centers for Medicare and Medicaid Services 2021 Proposed Physician Fee Schedule
2020-08-04 13:00 ET
iRhythm Technologies Comments on the Centers for Medicare and Medicaid Services 2021 Proposed Physician Fee Schedule
2020-07-29 20:05 ET
iRhythm Technologies to Present at the 40th Annual Canaccord Genuity Global Growth Conference
2020-07-21 20:05 ET
iRhythm Technologies to Report Second Quarter 2020 Financial Results on August 6, 2020
2019-04-02 20:41 ET
Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., iRhythm Technologies, Inc., Orion Group Holdings, Inc., Osmotica Pharmaceuticals plc, Quantenna Communications, Inc., WABCO Holdings, Inc. and Zafgen, Inc.

SEC forms

Show financial reports only

SEC form 8
2026-06-05 11:47 ET
iRhythm Technologies published news for 2026 q1
SEC form 10
2026-04-30 21:21 ET
iRhythm Technologies published news for 2026 q1
SEC form 8
2026-04-30 20:10 ET
iRhythm Technologies published news for 2026 q1
SEC form 8
2026-04-30 20:10 ET
iRhythm Technologies published news for 2026 q1
SEC form 8
2026-03-31 23:49 ET
iRhythm Technologies published news for 2025 q4
SEC form 8
2026-03-31 23:49 ET
iRhythm Technologies published news for 2025 q4
SEC form 10
2026-02-19 17:30 ET
iRhythm Technologies published news for 2025 q4
SEC form 8
2026-02-19 16:14 ET
iRhythm Technologies published news for 2025 q4
SEC form 8
2026-02-19 16:14 ET
iRhythm Technologies reported for 2025 q4
SEC form 8
2025-11-12 17:17 ET
iRhythm Technologies published news for 2025 q3
SEC form 8
2025-11-12 17:17 ET
iRhythm Technologies published news for 2025 q3
SEC form 10
2025-10-30 21:21 ET
iRhythm Technologies reported for 2025 q3
SEC form 10
2025-07-31 21:23 ET
iRhythm Technologies reported for 2025 q2
SEC form 8
2025-07-31 20:09 ET
iRhythm Technologies published news for 2025 q2
SEC form 8
2025-07-31 20:09 ET
iRhythm Technologies reported for 2025 q2
SEC form 10
2025-05-01 21:21 ET
iRhythm Technologies reported for 2025 q1
SEC form 10
2025-05-01 00:00 ET
iRhythm Technologies reported for 2025 q1
SEC form 10
2025-02-20 17:21 ET
iRhythm Technologies published news for 2024 q4
SEC form 8
2025-02-20 16:09 ET
iRhythm Technologies published news for 2024 q4
SEC form 8
2025-02-20 16:09 ET
iRhythm Technologies reported for 2024 q4
SEC form 10
2025-02-20 00:00 ET
iRhythm Technologies published news for 2024 q4
SEC form 10
2024-10-30 17:19 ET
iRhythm Technologies reported for 2024 q3
SEC form 8
2024-10-30 16:10 ET
iRhythm Technologies published news for 2024 q3
SEC form 8
2024-10-30 16:10 ET
iRhythm Technologies published news for 2024 q3
SEC form 10
2024-10-30 00:00 ET
iRhythm Technologies published news for 2024 q3
SEC form 10
2024-08-01 17:10 ET
iRhythm Technologies reported for 2024 q2
SEC form 8
2024-08-01 16:07 ET
iRhythm Technologies published news for 2024 q2
SEC form 8
2024-08-01 16:07 ET
iRhythm Technologies published news for 2024 q2
SEC form 8
2024-08-01 16:07 ET
iRhythm Technologies published news for 2024 q2
SEC form 10
2024-08-01 00:00 ET
iRhythm Technologies published news for 2024 q2
SEC form 10
2024-05-02 17:12 ET
iRhythm Technologies published news for 2024 q1
SEC form 8
2024-05-02 16:12 ET
iRhythm Technologies published news for 2024 q1
SEC form 8
2024-05-02 16:12 ET
iRhythm Technologies reported for 2024 q1
SEC form 10
2024-05-02 00:00 ET
iRhythm Technologies published news for 2024 q1
SEC form 10
2024-02-22 17:11 ET
iRhythm Technologies published news for 2023 q4
SEC form 8
2024-02-22 16:07 ET
iRhythm Technologies published news for 2023 q4
SEC form 8
2024-02-22 16:07 ET
iRhythm Technologies reported for 2023 q4
SEC form 10
2024-02-22 00:00 ET
iRhythm Technologies published news for 2023 q4
SEC form 10
2023-11-02 17:13 ET
iRhythm Technologies published news for 2023 q3
SEC form 8
2023-11-02 16:09 ET
iRhythm Technologies reported for 2023 q3
SEC form 10
2023-11-02 00:00 ET
iRhythm Technologies published news for 2023 q3
SEC form 10
2023-08-04 08:26 ET
iRhythm Technologies published news for 2023 q2
SEC form 10
2023-08-04 00:00 ET
iRhythm Technologies published news for 2023 q2
SEC form 6
2023-08-03 16:10 ET
iRhythm Technologies reported for 2023 q2
SEC form 8
2023-08-03 00:00 ET
iRhythm Technologies published news for 2023 q2
SEC form 6
2023-07-03 19:23 ET
iRhythm Technologies published news for 2023 q2
SEC form 6
2023-07-03 19:19 ET
iRhythm Technologies published news for 2023 q2
SEC form 6
2023-06-06 17:04 ET
iRhythm Technologies published news for 2023 q1
SEC form 6
2023-06-06 16:36 ET
iRhythm Technologies published news for 2023 q1
SEC form 6
2023-06-06 09:05 ET
iRhythm Technologies published news for 2023 q1
SEC form 6
2023-06-05 16:28 ET
iRhythm Technologies published news for 2023 q1
SEC form 6
2023-06-05 16:25 ET
iRhythm Technologies published news for 2023 q1
SEC form 6
2023-06-05 16:07 ET
iRhythm Technologies published news for 2023 q1
SEC form 10
2023-05-04 00:00 ET
iRhythm Technologies published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
iRhythm Technologies published news for 2023 q1
SEC form 6
2023-03-15 17:09 ET
iRhythm Technologies published news for 2022 q4
SEC form 6
2023-03-10 17:19 ET
iRhythm Technologies published news for 2022 q4
SEC form 6
2023-03-01 18:30 ET
iRhythm Technologies published news for 2022 q4
SEC form 6
2023-03-01 18:26 ET
iRhythm Technologies published news for 2022 q4
SEC form 6
2023-03-01 18:22 ET
iRhythm Technologies published news for 2022 q4
SEC form 6
2023-03-01 18:20 ET
iRhythm Technologies published news for 2022 q4
SEC form 6
2023-03-01 18:17 ET
iRhythm Technologies published news for 2022 q4
SEC form 6
2023-03-01 18:14 ET
iRhythm Technologies published news for 2022 q4
SEC form 6
2023-03-01 18:09 ET
iRhythm Technologies published news for 2022 q4
SEC form 6
2023-03-01 18:05 ET
iRhythm Technologies published news for 2022 q4
SEC form 6
2023-03-01 18:01 ET
iRhythm Technologies published news for 2022 q4
SEC form 6
2023-03-01 17:57 ET
iRhythm Technologies published news for 2022 q4
SEC form 10
2023-02-23 17:16 ET
iRhythm Technologies reported for 2022 q4
SEC form 6
2023-02-23 16:07 ET
iRhythm Technologies published news for 2022 q4
SEC form 10
2023-02-23 00:00 ET
iRhythm Technologies reported for 2022 q4
SEC form 8
2023-02-23 00:00 ET
iRhythm Technologies reported for 2022 q4
SEC form 10
2022-11-04 17:07 ET
iRhythm Technologies reported for 2022 q3
SEC form 10
2022-11-04 00:00 ET
iRhythm Technologies reported for 2022 q3
SEC form 6
2022-11-01 16:06 ET
iRhythm Technologies published news for 2022 q3
SEC form 8
2022-11-01 00:00 ET
iRhythm Technologies reported for 2022 q3
SEC form 6
2022-09-21 09:04 ET
iRhythm Technologies published news for 2022 q2
SEC form 6
2022-08-10 17:18 ET
iRhythm Technologies published news for 2022 q2
SEC form 10
2022-08-05 16:36 ET
iRhythm Technologies reported for 2022 q2
SEC form 10
2022-08-05 00:00 ET
iRhythm Technologies reported for 2022 q2
SEC form 8
2022-08-05 00:00 ET
iRhythm Technologies reported for 2022 q2
SEC form 6
2022-08-04 17:35 ET
iRhythm Technologies published news for 2022 q2
SEC form 6
2022-07-27 16:14 ET
iRhythm Technologies published news for 2022 q2
SEC form 6
2022-07-27 16:10 ET
iRhythm Technologies published news for 2022 q2
SEC form 6
2022-07-25 17:25 ET
iRhythm Technologies published news for 2022 q2
SEC form 6
2022-07-18 19:15 ET
iRhythm Technologies published news for 2022 q2
SEC form 6
2022-06-14 15:20 ET
iRhythm Technologies published news for 2022 q1
SEC form 6
2022-06-14 15:16 ET
iRhythm Technologies published news for 2022 q1
SEC form 6
2022-06-08 14:09 ET
iRhythm Technologies published news for 2022 q1
SEC form 6
2022-06-01 17:40 ET
iRhythm Technologies published news for 2022 q1
SEC form 6
2022-05-27 17:45 ET
iRhythm Technologies published news for 2022 q1
SEC form 10
2022-05-06 16:10 ET
iRhythm Technologies reported for 2022 q1
SEC form 10
2022-05-06 00:00 ET
iRhythm Technologies reported for 2022 q1
SEC form 6
2022-05-05 16:09 ET
iRhythm Technologies published news for 2022 q1
SEC form 8
2022-05-05 00:00 ET
iRhythm Technologies reported for 2022 q1
SEC form 6
2022-04-14 16:36 ET
iRhythm Technologies published news for 2022 q1
SEC form 6
2022-03-29 16:08 ET
iRhythm Technologies published news for 2021 q4
SEC form 6
2022-03-14 08:44 ET
iRhythm Technologies published news for 2021 q4
SEC form 6
2022-03-02 16:28 ET
iRhythm Technologies published news for 2021 q4
SEC form 10
2022-02-28 08:03 ET
iRhythm Technologies published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
iRhythm Technologies published news for 2021 q4
SEC form 6
2022-02-23 16:12 ET
iRhythm Technologies published news for 2021 q4
SEC form 8
2022-02-23 00:00 ET
iRhythm Technologies published news for 2021 q4
SEC form 6
2021-12-14 17:12 ET
iRhythm Technologies published news for 2021 q3
SEC form 6
2021-12-01 16:03 ET
iRhythm Technologies published news for 2021 q3
SEC form 10
2021-11-05 16:04 ET
iRhythm Technologies published news for 2021 q3
SEC form 10
2021-11-05 00:00 ET
iRhythm Technologies published news for 2021 q3
SEC form 6
2021-11-04 16:11 ET
iRhythm Technologies published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
iRhythm Technologies published news for 2021 q3
SEC form 6
2021-10-12 16:11 ET
iRhythm Technologies published news for 2021 q3
SEC form 6
2021-10-05 16:22 ET
iRhythm Technologies published news for 2021 q3
SEC form 6
2021-09-13 16:02 ET
iRhythm Technologies published news for 2021 q2
SEC form 6
2021-09-13 08:17 ET
iRhythm Technologies published news for 2021 q2
SEC form 10
2021-08-09 06:31 ET
iRhythm Technologies published news for 2021 q2
SEC form 10
2021-08-09 00:00 ET
iRhythm Technologies published news for 2021 q2
SEC form 6
2021-08-05 16:22 ET
iRhythm Technologies published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
iRhythm Technologies published news for 2021 q2
SEC form 6
2021-07-06 16:01 ET
iRhythm Technologies published news for 2021 q2
SEC form 6
2021-06-21 16:06 ET
iRhythm Technologies published news for 2021 q1
SEC form 6
2021-06-01 16:10 ET
iRhythm Technologies published news for 2021 q1
SEC form 10
2021-05-10 17:03 ET
iRhythm Technologies published news for 2021 q1
SEC form 6
2021-05-10 16:16 ET
iRhythm Technologies published news for 2021 q1
SEC form 10
2021-05-10 00:00 ET
iRhythm Technologies published news for 2021 q1
SEC form 6
2021-05-06 16:13 ET
iRhythm Technologies published news for 2021 q1
SEC form 8
2021-05-06 00:00 ET
iRhythm Technologies published news for 2021 q1
SEC form 6
2021-04-30 16:27 ET
iRhythm Technologies published news for 2021 q1
SEC form 6
2021-04-12 07:03 ET
iRhythm Technologies published news for 2021 q1
SEC form 8
2021-04-12 00:00 ET
iRhythm Technologies published news for 2021 q1
SEC form 10
2021-02-26 17:06 ET
iRhythm Technologies published news for 2020 q4
SEC form 6
2021-02-25 16:12 ET
iRhythm Technologies published news for 2020 q4
SEC form 6
2021-02-01 08:08 ET
iRhythm Technologies published news for 2020 q4
SEC form 6
2021-01-28 16:20 ET
iRhythm Technologies published news for 2020 q4
SEC form 6
2021-01-15 20:22 ET
iRhythm Technologies published news for 2020 q4
SEC form 6
2020-12-14 16:43 ET
iRhythm Technologies published news for 2020 q3
SEC form 6
2020-12-02 06:21 ET
iRhythm Technologies published news for 2020 q3
SEC form 6
2020-11-16 12:12 ET
iRhythm Technologies published news for 2020 q3
SEC form 10
2020-11-06 16:05 ET
iRhythm Technologies published news for 2020 q3
SEC form 6
2020-11-05 16:11 ET
iRhythm Technologies published news for 2020 q3
SEC form 6
2020-10-06 16:04 ET
iRhythm Technologies published news for 2020 q3
SEC form 6
2020-10-06 16:03 ET
iRhythm Technologies published news for 2020 q3